Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 284
Selected: 0
NCT IDTitle
NCT04466891A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers
NCT02167685The Chimerix CMX001 Registry
NCT03572764CPX-351 (Vyxeos™) for Transplant Eligible, Higher Risk Patients With Myelodysplastic Syndrome
NCT05974293A Phase IIb Study of Nabiximols for Spasticity Due to Neuromyelitis Optica Spectrum Disorders
NCT04145531An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)
NCT05091567A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer
NCT01424566A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer
NCT02332655Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome
NCT03575325Vyxeos(CPX-351) in Adults w R/R Acute Lymphoblastic Leukemia
NCT01606176A Study to Evaluate the Effects of Cannabis Based Medicine in Patients With Pain of Neurological Origin
NCT03865589Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome
NCT01337089Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
NCT01461915Phase 2 Study to Assess the Efficacy & Safety of Gemcitabine + Nab Paclitaxel With or Without Dociparstat in Metastatic Pancreatic Cancer Patients
NCT01217112GWMD1092 - GWP42003 : GWP42004 Together Plus Alone in Type II Diabetes
NCT04982354Induction Therapy for Patients With FLT3 Mutated Acute Myeloid Leukemia
NCT01886105Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma
NCT06261502Effect of CANnabidiol on Anxiety and GABAergic Function in Individuals with Fragile-X Syndrome
NCT02863991Oral ONC201 in Relapsed/Refractory Multiple Myeloma
NCT00675948Study to Compare the Safety and Tolerability of Sativex® in Patients With Cancer Related Pain
NCT05875974A Study to Investigate the Effect of XYWAV on Sleepiness, Polysomnography, and Functional Outcomes in Participants With Idiopathic Hypersomnia or Narcolepsy
NCT00711646A Study of Sativex® for Relief of Spasticity in Subjects With Multiple Sclerosis.
NCT04899947Child and Adolescent Registry for Participants With Narcolepsy
NCT01599234A Study to Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple Sclerosis
NCT02851407Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients
NCT04899050Epidiolex in Typical Absence Seizures
NCT00674609A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy
NCT01943682Safety Study of CPX-351 in Children With Relapsed Leukemia or Lymphoma
NCT05558124CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML
NCT02439970A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Disease
NCT04485104Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures
NCT03954106A Safety and Efficacy Study of Defibrotide in the Prevention of Chimeric Antigen Receptor-T-cell-associated Neurotoxicity
NCT04803786A Patient-Centric, Prospective, Observational, Non-Interventional Switch Study of XYWAV in Narcolepsy
NCT04252586A Long-term Safety Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome
NCT07102381A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
NCT04231851CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute Myeloid Leukemia
NCT05229588Lurbinectedin in Patients With Advanced Gastrointestinal Malignancies With DNA Repair Mutations
NCT04285788Incidence and Outcomes Associated With the Management of Adenovirus Infections in Allogenic Hematopoietic Cell Transplant Recipients
NCT00678795A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple Sclerosis
NCT05485831Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY
NCT06217536Neoadjuvant Lurbinectedin and Preoperative Radiation for Treating Soft Tissue Sarcomas
NCT00457951A Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPD
NCT07176312Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) Patients
NCT00003966Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation
NCT04421456Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment
NCT00780182Comparative Bioavailability and Effect of Food on CMX001 in Healthy Volunteers
NCT05733390A Study of JZP541 in Adults With Irritability Associated With Autism Spectrum Disorder
NCT02073474An Observational Post-Marketing Safety Registry of Sativex®
NCT06108050JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
NCT01551524Phase I Study of mPEG-R-Crisantaspase Given IV
NCT01843634Ph I Safety and Efficacy of ODSH in Patients Receiving Induction or Consolidation Therapy for Acute Myeloid Leukemia